Industry Educational Session - Uncovering the Hidden Impact of Immune thrombocytopenia (ITP) on patients - Sponsored by Novartis
Tracks
-
| Sunday, April 27, 2025 |
| 3:45 PM - 4:15 PM |
| M2 & M3 |
Details
Immune thrombocytopenia (ITP) significantly impairs patients' quality of life (QoL). Current therapies often fail to provide durable responses after discontinuation, necessitating long-term treatment and further burdening patients' QoL.
Join us at this symposium where we bring together healthcare professionals (HCPs) and patient advocates to hear directly from ITP patients, offering valuable insights and diverse perspectives on the impact of ITP.
This non-promotional symposium is organised and funded by Novartis Pharmaceuticals UK, Ltd, intended for UK healthcare professionals only. The speakers have been offered an honorarium for their involvement in this programme.
UK | March 2025 | FA-11392110
Speaker
Mervyn Morgan
CEO of ITP Support Association (UK and Ireland)
- Session Chair
Prof. Nichola Cooper
Professor of Immune Haematology
Imperial College London
- Speaker
Dr Charlotte Bradbury
Consultant Haematologist
University of Bristol
- Speaker
ITP Patient
-
